Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis.

about

The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma.Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.

P2860

Q40522294-1DB4C847-68D0-4338-AFDB-9B0BF38B40FA Q43379691-362EBF3F-5603-4844-96B3-142A722E6F57

P2860

Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis.

Item

http://www.wikidata.org/entity/Q40576636

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Deliverability and efficacy of ...... ralian retrospective analysis.

@en

type

Item

label

Deliverability and efficacy of ...... ralian retrospective analysis.

@en

prefLabel

Deliverability and efficacy of ...... ralian retrospective analysis.

@en

P1476

Deliverability and efficacy of ...... ralian retrospective analysis.

@en

P2093

A Caudron

http://www.w3.org/2001/XMLSchema#string

A Millar

http://www.w3.org/2001/XMLSchema#string

B Webster

http://www.w3.org/2001/XMLSchema#string

J Fletcher

http://www.w3.org/2001/XMLSchema#string

M Ellis

http://www.w3.org/2001/XMLSchema#string

T Cochrane

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Cancer statistics, 2007

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

The coming acceleration of global population ageing.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.

Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma

P304

1147-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMJ.12889

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Mollee

J Trotman

P577

2015-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26337606

http://www.w3.org/2001/XMLSchema#string

Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis.

about

P2860

P2860

Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698